Detalles de la búsqueda
1.
Treatment patterns and prognosis in patients with Bacillus Calmette-Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysis.
World J Urol
; 42(1): 185, 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38512511
2.
The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin therapy.
Jpn J Clin Oncol
; 54(2): 192-200, 2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37974430
3.
Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy.
Int J Urol
; 31(5): 526-533, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240169
4.
Effect of improvement measures in reducing interruptions in a Japanese hospital pharmacy using a synthetic approach based on resilience engineering and systems thinking.
BMC Health Serv Res
; 23(1): 331, 2023 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37013551
5.
Plasma circulating tumor DNA profiling in patients with chemo-refractory germ cell tumors.
Int J Urol
; 30(5): 456-462, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36746673
6.
C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin therapy: A Japan Urological Oncology Group study analysis.
Int J Urol
; 30(3): 299-307, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36448522
7.
[Two Cases of Femoral Nerve Palsy after Pelvic Surgery].
Hinyokika Kiyo
; 69(1): 25-28, 2023 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-36727458
8.
ELOVL5-mediated fatty acid elongation promotes cellular proliferation and invasion in renal cell carcinoma.
Cancer Sci
; 113(8): 2738-2752, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35670054
9.
Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR.
Cancer Immunol Immunother
; 71(2): 461-471, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34235546
10.
IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation.
BMC Cancer
; 22(1): 1292, 2022 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36494792
11.
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis.
BJU Int
; 130(2): 226-234, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34110696
12.
Overview of clinical management for older patients with renal cell carcinoma.
Jpn J Clin Oncol
; 52(7): 665-681, 2022 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35397166
13.
Narrative review of local prostate and metastasis-directed radiotherapy in the treatment of metastatic prostate cancer.
Jpn J Clin Oncol
; 52(6): 633-641, 2022 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35325157
14.
Real-world effectiveness of nivolumab plus ipilimumab and second-line therapy in Japanese untreated patients with metastatic renal cell carcinoma: 2-year analysis from a multicenter retrospective clinical study (J-cardinal study).
Jpn J Clin Oncol
; 52(11): 1345-1352, 2022 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35920793
15.
Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi-institutional retrospective study.
Int J Clin Oncol
; 27(3): 563-573, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34973106
16.
Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study.
Int J Clin Oncol
; 27(1): 154-164, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34800178
17.
Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data.
Int J Clin Oncol
; 27(5): 958-968, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35142962
18.
Cancer-specific and net overall survival in older patients with de novo metastatic prostate cancer initially treated with androgen deprivation therapy.
Int J Urol
; 29(10): 1147-1154, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35613936
19.
Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumors.
Int J Urol
; 29(7): 741-747, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35462438
20.
Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer.
Int J Urol
; 29(10): 1195-1203, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35858755